News

Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning ...
"Merck has donated MECTIZAN for more than 20 years and will continue to do so until river blindness becomes a disease of the past," said Richard T. Clark, chairman and CEO of Merck. "We are inspired ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the company, together with the Mectizan Donation Program, is donating $1 million to the END Fund in support ...
On World Sight Day, Merck and Partners Mark 25 Years of Successful Collaboration To Help Eliminate River Blindness. Media:Kelley Dougherty, 908-423-4291Justine O'Malley, 908-423 2021Investor:Carol ...
In 1987, Dr. Roy Vagelos announced that Merck & Co., Inc. would donate ivermectin for the prevention of River Blindness. Over the subsequent 30 years, some 2 billion treatments were distributed. The ...
Brian O. L. Duke, a tropical disease expert and early advocate for free drugs to treat river blindness, a vicious and preventable scourge that afflicts the world’s poor, died June 3 at home in ...
Merck says it has no estimate of how much the effort has cost, but the United Nations says river blindness may be eradicated by 2007. "Merck is really the pioneer," says Jordan Kassalow, former ...
Dr. Kenneth Brown — who wrote the Merck & Co. research protocols to study ivermectin as a treatment for river blindness — was ecstatic to learn the drug inhibited the SARS CoV-2 virus in the ...
Public Health Officials Confirm Significant Progress Toward the Goal of Elimination of River Blindness in Latin America by 2012 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Public health officials at ...
World Health Organization commends the MECTIZAN ® Donation Program on its contribution to near-elimination of river blindness from the Western Hemisphere Partnership efforts result in ...